RECRUITING

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Official Title

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction: a Randomized Control Trial

Quick Facts

Study Start:2024-08-19
Study Completion:2029-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06511232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft
  2. * Patients aged between 18-40 years old at the time of surgery
  1. * Patients undergoing ACL reconstruction with any other type of autograft or allograft other than BTB
  2. * Patients younger than 18 years old or older than 40 years old
  3. * Patients undergoing meniscal root repair or any other repair that changes their weight-bearing status
  4. * Patients with a history of substance abuse
  5. * Vulnerable populations
  6. * Patients on chronic pain medication within the last 6 months
  7. * BMI \>/= 35
  8. * Allergy to morphine
  9. * Unwilling to participate
  10. * Any additional reason the PI deems reasonable

Contacts and Locations

Study Contact

Haley Goble, MHA
CONTACT
713-441-3930
hmgoble@houstonmethodist.org

Principal Investigator

Robert Jack, MD
PRINCIPAL_INVESTIGATOR
The Methodist Hospital Research Institute

Study Locations (Sites)

Houston Methodist Research Institute
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The Methodist Hospital Research Institute

  • Robert Jack, MD, PRINCIPAL_INVESTIGATOR, The Methodist Hospital Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-19
Study Completion Date2029-07-31

Study Record Updates

Study Start Date2024-08-19
Study Completion Date2029-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Anterior Cruciate Ligament Tear
  • Anterior Cruciate Ligament Injuries
  • Anterior Cruciate Ligament Rupture